Association Between Sarcopenia and Cognitive Impairment in the Older People: a Meta-analysis

Overview

Journal Eur Geriatr Med

Specialty Geriatrics

Date 2022 Jun 7

PMID 35670963

Authors

Xu Chen

Mingjie Cao

Min Liu

Shuping Liu

Zilong Zhao

Huiying Chen

Affiliations

Soon will be listed here.

Abstract

Purpose: The effects of sarcopenia on the older people are profound, increasing the risk of adverse outcomes for older patients. Although the substantial impact of sarcopenia on maintaining functional independence and adverse health outcomes has been described many times in the past, the link between sarcopenia and cognitive impairment in older adults remains lacking in evidence and controversial. Therefore, we conducted a comprehensive search of available national and international databases and carried out a meta-analysis to examine the association between sarcopenia in older people and cognitive impairment.

Methods: Relevant experiments had been recognized via looking out electronic databases and conference sessions. The present study included case-control, cohort, or cross-sectional studies of the association between sarcopenia and cognitive impairment in the older people.

Results: The meta-analysis included 26 articles and 18,788 participants were involved after assessment of eligibility. The results of this meta-analysis showed that the risk of developing cognitive impairment was significantly higher in patients with sarcopenia than in those without sarcopenia [OR = 1.75; 95% CI = 1.57, 1.95; P < 0.00001], MMSE score of sarcopenia group was lower than that of non-sarcopenia group, the difference was statistically significant [OR = - 2.23; 95% CI = - 2.48, - 1.99; P < 0.00001].

Conclusion: Overall, this meta-analysis showed an association between sarcopenia and cognitive impairment in the older people, demonstrating a significant association between sarcopenia and cognitive impairment. This suggested that providing comprehensive sarcopenia screening and active prevention for the older people with cognitive decline has certain clinical value for improving the quality of life of the older people.

Citing Articles

A prediction model for the risk of developing mild cognitive impairment in older adults with sarcopenia: evidence from the CHARLS.

Liu X, Ni J, Wang B, Yin R, Tang J, Chu Q Aging Clin Exp Res. 2025; 37(1):69.

PMID: 40055290 PMC: 11889009. DOI: 10.1007/s40520-025-02980-2.

Association between sensory impairment and sarcopenia in older Chinese adults: a 4-Year longitudinal study.

Huang C, He X BMC Geriatr. 2025; 25(1):90.

PMID: 39934655 PMC: 11817050. DOI: 10.1186/s12877-024-05642-6.

Sakita M, Isobe W, Nonaka K, Murakami S, Miyachi R, Sakane K Biomed Rep. 2025; 22(3):50.

PMID: 39882333 PMC: 11775640. DOI: 10.3892/br.2025.1928.

A causal relationship between sarcopenia and cognitive impairment: A Mendelian randomization study.

Liu H, Fan Y, Liang J, Hu A, Chen W, Wang H PLoS One. 2024; 19(9):e0309124.

PMID: 39240885 PMC: 11379137. DOI: 10.1371/journal.pone.0309124.

What is the most appropriate handgrip strength testing protocol for sarcopenia screening in older adults with cognitive impairment?.

Garcia P, Sampaio R, Moura J, de Souza P, da Costa L, Mendes F Braz J Phys Ther. 2024; 28(4):101104.

PMID: 39146868 PMC: 11375251. DOI: 10.1016/j.bjpt.2024.101104.

References

Cruz-Jentoft A, Landi F, Schneider S, Zuniga C, Arai H, Boirie Y . Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014; 43(6):748-59. PMC: 4204661. DOI: 10.1093/ageing/afu115. View

Mayhew A, Amog K, Phillips S, Parise G, McNicholas P, de Souza R . The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2018; 48(1):48-56. DOI: 10.1093/ageing/afy106. View

Beaudart C, Zaaria M, Pasleau F, Reginster J, Bruyere O . Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS One. 2017; 12(1):e0169548. PMC: 5240970. DOI: 10.1371/journal.pone.0169548. View

Visser M, Schaap L . Consequences of sarcopenia. Clin Geriatr Med. 2011; 27(3):387-99. DOI: 10.1016/j.cger.2011.03.006. View

Baumgart M, Snyder H, Carrillo M, Fazio S, Kim H, Johns H . Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement. 2015; 11(6):718-26. DOI: 10.1016/j.jalz.2015.05.016. View

Cesari M, Landi F, Vellas B, Bernabei R, Marzetti E . Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosci. 2014; 6:192. PMC: 4112807. DOI: 10.3389/fnagi.2014.00192. View

Tolea M, Galvin J . Sarcopenia and impairment in cognitive and physical performance. Clin Interv Aging. 2015; 10:663-71. PMC: 4388078. DOI: 10.2147/CIA.S76275. View

Xu W, Chen T, Shan Q, Hu B, Zhao M, Deng X . Sarcopenia Is Associated with Cognitive Decline and Falls but Not Hospitalization in Community-Dwelling Oldest Old in China: A Cross-Sectional Study. Med Sci Monit. 2020; 26:e919894. PMC: 6998786. DOI: 10.12659/MSM.919894. View

Aliberti M, Szlejf C, Covinsky K, Lee S, Jacob-Filho W, Suemoto C . Prognostic value of a rapid sarcopenia measure in acutely ill older adults. Clin Nutr. 2019; 39(7):2114-2120. PMC: 8454415. DOI: 10.1016/j.clnu.2019.08.026. View

10.

Rodriguez-Rejon A, Ruiz-Lopez M, Artacho Martin-Lagos R . [Diagnosis and prevalence of sarcopenia in long-term care homes: EWGSOP2 versus EWGSOP1]. Nutr Hosp. 2019; 36(5):1074-1080. DOI: 10.20960/nh.02573. View

11.

Bellelli G, Zambon A, Volpato S, Abete P, Bianchi L, Bo M . The association between delirium and sarcopenia in older adult patients admitted to acute geriatrics units: Results from the GLISTEN multicenter observational study. Clin Nutr. 2017; 37(5):1498-1504. DOI: 10.1016/j.clnu.2017.08.027. View

12.

Ogawa Y, Kaneko Y, Sato T, Shimizu S, Kanetaka H, Hanyu H . Sarcopenia and Muscle Functions at Various Stages of Alzheimer Disease. Front Neurol. 2018; 9:710. PMC: 6121095. DOI: 10.3389/fneur.2018.00710. View

13.

Hao Q, Hu X, Xie L, Chen J, Jiang J, Dong B . Prevalence of sarcopenia and associated factors in hospitalised older patients: A cross-sectional study. Australas J Ageing. 2018; 37(1):62-67. DOI: 10.1111/ajag.12492. View

14.

Tang T, Hwang A, Liu L, Lee W, Chen L, Wu Y . FNIH-defined Sarcopenia Predicts Adverse Outcomes Among Community-Dwelling Older People in Taiwan: Results From I-Lan Longitudinal Aging Study. J Gerontol A Biol Sci Med Sci. 2017; 73(6):828-834. DOI: 10.1093/gerona/glx148. View

15.

Lee I, Cho J, Hong H, Jin Y, Kim D, Kang H . Sarcopenia Is Associated with Cognitive Impairment and Depression in Elderly Korean Women. Iran J Public Health. 2018; 47(3):327-334. PMC: 5971168. View

16.

Maeda K, Akagi J . Cognitive impairment is independently associated with definitive and possible sarcopenia in hospitalized older adults: The prevalence and impact of comorbidities. Geriatr Gerontol Int. 2016; 17(7):1048-1056. DOI: 10.1111/ggi.12825. View

17.

Henwood T, Hassan B, Swinton P, Senior H, Keogh J . Consequences of sarcopenia among nursing home residents at long-term follow-up. Geriatr Nurs. 2017; 38(5):406-411. DOI: 10.1016/j.gerinurse.2017.02.003. View

18.

Sugimoto T, Ono R, Murata S, Saji N, Matsui Y, Niida S . Prevalence and associated factors of sarcopenia in elderly subjects with amnestic mild cognitive impairment or Alzheimer disease. Curr Alzheimer Res. 2016; 13(6):718-26. DOI: 10.2174/1567205013666160211124828. View

19.

Huang C, Hwang A, Liu L, Lee W, Chen L, Peng L . Association of Dynapenia, Sarcopenia, and Cognitive Impairment Among Community-Dwelling Older Taiwanese. Rejuvenation Res. 2015; 19(1):71-8. DOI: 10.1089/rej.2015.1710. View

20.

Beaudart C, Reginster J, Petermans J, Gillain S, Quabron A, Locquet M . Quality of life and physical components linked to sarcopenia: The SarcoPhAge study. Exp Gerontol. 2015; 69:103-10. DOI: 10.1016/j.exger.2015.05.003. View